Ebola vaccine trial

Numéro d’image : 11687537
Ebola vaccine trial
Ebola vaccine trial. Man receiving a dose of the investigational NIAID/GSK ebola vaccine. This trial will determine if the vaccine is safe in humans and if it induces an adequate immune response. The vaccine uses a chimpanzee cold virus (chimp adenovirus type 3) to carry segments of genetic material from two ebola viruses. The viruses cause ebola virus disease (EVD),a severe and often fatal disease with symptoms including fever,fatigue,muscle aches,vomiting,diarrhoea and haemorrhaging (internal bleeding). It is spread through direct contact with infected bodily fluids. There is no cure for the disease,but three quarters of patients can recover if provided with sufficient medical support. Photographed at the NIH Clinical Center,Bethesda,Maryland,USA,on 4th September 2014
Licence : Droits gérés
Crédit: Science Photo Library / NATIONAL INSTITUTES OF HEALTH
Taille de l’image : 3500 px × 2500 px
Model Release : Non requis
Property Release : Non requis
Restrictions : -

Prix pour cette image À partir de 45 €

Produit vendu
(Calendrier, Carte postale, Carte de vœux, Impression sur textile, Packaging etc)
À partir de 45 €
Usage commercial
(Affichage, Annonce presse, Annonce TV, Carte, Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 45 €
Éditorial
(Digital, Journal, Livre, Livre pratique, Magazine, Télévision etc)
À partir de 60 €
Usage non-commercial
(Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 120 €

Mots clés

;